CORINALDESI, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 14.438
AS - Asia 10.726
EU - Europa 8.851
AF - Africa 594
SA - Sud America 536
Continente sconosciuto - Info sul continente non disponibili 427
OC - Oceania 31
AN - Antartide 1
Totale 35.604
Nazione #
US - Stati Uniti d'America 14.243
VN - Vietnam 3.232
SG - Singapore 2.723
CN - Cina 2.636
GB - Regno Unito 2.353
IT - Italia 1.507
DE - Germania 1.246
SE - Svezia 777
HK - Hong Kong 767
UA - Ucraina 600
FR - Francia 531
IN - India 460
RU - Federazione Russa 405
BR - Brasile 377
FI - Finlandia 298
IE - Irlanda 298
CH - Svizzera 210
JP - Giappone 181
NL - Olanda 180
ZA - Sudafrica 142
EE - Estonia 137
KR - Corea 137
TG - Togo 131
BD - Bangladesh 115
CI - Costa d'Avorio 115
CA - Canada 111
NG - Nigeria 96
JO - Giordania 82
PH - Filippine 75
AT - Austria 70
AR - Argentina 61
BG - Bulgaria 56
SC - Seychelles 55
TH - Thailandia 50
BE - Belgio 35
IQ - Iraq 35
ID - Indonesia 34
MX - Messico 34
AU - Australia 30
TW - Taiwan 29
EC - Ecuador 28
IR - Iran 28
PL - Polonia 27
TR - Turchia 27
GR - Grecia 23
PK - Pakistan 20
CL - Cile 19
SA - Arabia Saudita 19
ES - Italia 17
HR - Croazia 16
UZ - Uzbekistan 15
CO - Colombia 14
LB - Libano 13
LT - Lituania 12
RO - Romania 12
EG - Egitto 11
PY - Paraguay 11
TN - Tunisia 11
JM - Giamaica 10
MA - Marocco 10
MY - Malesia 9
PE - Perù 9
CZ - Repubblica Ceca 8
DZ - Algeria 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
IL - Israele 6
NI - Nicaragua 6
PT - Portogallo 6
SI - Slovenia 6
SV - El Salvador 6
UY - Uruguay 6
CR - Costa Rica 5
GH - Ghana 5
HU - Ungheria 5
SK - Slovacchia (Repubblica Slovacca) 5
A2 - ???statistics.table.value.countryCode.A2??? 4
GT - Guatemala 4
NP - Nepal 4
OM - Oman 4
TT - Trinidad e Tobago 4
AZ - Azerbaigian 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
KW - Kuwait 3
PR - Porto Rico 3
RS - Serbia 3
BA - Bosnia-Erzegovina 2
BS - Bahamas 2
HN - Honduras 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
MU - Mauritius 2
PA - Panama 2
PS - Palestinian Territory 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
Totale 35.161
Città #
Southend 2.079
Houston 2.001
Singapore 1.842
Ashburn 1.278
Fairfield 1.012
Dong Ket 868
Chandler 770
Hong Kong 711
San Jose 666
Santa Clara 570
Ho Chi Minh City 549
Hanoi 521
Woodbridge 508
Wilmington 464
Seattle 462
Jacksonville 396
Princeton 385
Ann Arbor 352
Cambridge 352
Council Bluffs 347
Beijing 339
Hefei 335
Munich 310
Dublin 294
Boardman 267
Helsinki 261
New York 232
Los Angeles 211
Bern 190
Padova 181
Lauterbourg 171
Westminster 168
Nanjing 167
Milan 144
Tokyo 140
Berlin 136
Bologna 134
Lomé 131
Dallas 118
Abidjan 115
Seoul 105
Buffalo 100
Jinan 96
Shenyang 86
Amman 81
Rome 79
Haiphong 76
Changsha 75
Guangzhou 75
Saint Petersburg 75
Mülheim 73
Da Nang 72
Bremen 69
Shanghai 65
Abeokuta 64
San Diego 59
Tianjin 59
Medford 57
São Paulo 57
Nanchang 54
Sofia 54
Washington 53
Florence 52
Hebei 50
Phoenix 48
Vienna 46
Turin 44
Frankfurt am Main 43
Redondo Beach 43
Mahé 40
Dearborn 39
Bengaluru 38
Toronto 38
Haikou 37
San Francisco 35
Yubileyny 35
Des Moines 34
Falls Church 34
Atlanta 33
Verona 32
Zhengzhou 32
Hyderabad 31
Orem 31
Chicago 30
Hangzhou 30
Ningbo 30
Brussels 28
Montreal 28
Hải Dương 27
Shenzhen 26
Biên Hòa 25
Falkenstein 25
London 25
Brooklyn 24
Jiaxing 24
Lagos 24
Norwalk 24
Taizhou 24
Fuzhou 23
Bắc Ninh 22
Totale 23.015
Nome #
New pathophysiological mechanisms in irritable bowel syndrome. 1.819
Seasonal pattern of peptic ulcer hospitalizations: analysis of the hospital discharge data of the Emilia-Romagna region of Italy. 557
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 434
Chronic Intestinal Pseudo-Obstruction: A Neuropathological Approach 367
La sindrome dell'intestino irritabile. 359
Salmonella gastroenteritis during childhood is a risk factor for irritable bowel syndrome in adulthood 353
Acute pancreatitis due to simvastatin therapy: increased severity after rechallenge. 333
Randomised controlled trial of mesalazine in IBS 331
Il sistema nervoso enterico. 311
Chronic intestinal pseudo-obstruction related to viral infections. 308
Molecular and Pathological characterization of a non-aganglionic congenital megacolon in the rabbit 308
Use of macrogol 4000 in chronic constipation. 306
Abnormalities of somatic peptide-containing nerves supplying the pelvic floor of women with genitourinary prolapse and stress urinary incontinence. 279
Neoadjuvant therapy for resectable pancreatic adenocarcinoma: a single center prospective, randomized controlled study. 262
Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons 261
Sigmoid compliance and visceral perception in spinal cord injury patients 250
Diagnosis and therapy of irritable bowel syndrome 244
Anti-ganglioside antibodies in coeliac disease with neurological disorders. 243
Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. 241
A-Transducin, a Signaling Molecule of the Chemoreceptive Cascade, Is Expressed in Endocrine and Non-Endocrine Cells of the Pig Gastrointestinal Mucosa 239
Basis for treatment of functioning neuroendocrine tumours. 237
A novel locus for syndromic chronic idiopathic intestinal pseudo-obstruction maps to chromosome 8q23-q24. 234
Chronic intestinal pseudo-obstruction: manifestations, natural history and management. 233
Altered Serotonin Signaling and Extrinsic Sensory Neuron Activation in Irritable Bowel Syndrome 230
Chromogranin A: is it a useful marker of neuroendocrine tumors? 228
Contrast-enhanced ultrasound in the differential diagnosis of exocrine versus neuroendocrine pancreatic tumors 226
New insights into human enteric neuropathies. 224
L’encefalomiopatia Mitocondriale Neurogastrointestinale (MNGIE): Il Fegato Come Nuova Fonte Di Timidina Fosforilasi 224
Adult coeliac disease diagnosed by endoscopic biopsies in the duodenal bulb. 224
Endocrine pancreatic tumors: factors correlated with survival. 222
The immune system in irritable bowel syndrome. 222
Chemosensitività intestinale, nervi, cellule enteroendocrine, recettori del gusto 221
Chronic asymptomatic pancreatic hyperenzymemia is a benign condition in only half of the cases: a prospective study 220
A case of primary pancreatic lymphoma. 219
Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome. 218
Aminosalicylates and other anti-inflammatory compounds for irritable bowel syndrome. 216
Chronic intestinal pseudo-obstruction. 212
The ELISA fecal elastase-1 polyclonal assay reacts with different antigens than those of the monoclonal assay. 211
MALATTIA DA REFLUSSO GASTROESOFAGEO 208
Duodenal histology in patients with celiac disease after a gluten-free diet 203
JC virus infects the enteric glia of patients with chronic idiopathic intestinal pseudo-obstruction. 201
Expression and regulation of α-transducin in the pig gastrointestinal tract 197
Interstitial lung disease (ILD) and gastroesophageal reflux (GER) 196
Mechanisms underlying visceral hypersensitivity in irritable bowel syndrome 194
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 190
Neuroplasticity of the enteric nervous system induced by inflammatory conditions in the gut 190
Endocrine tumors of the ileum: factors correlated with survival. 190
Gastroesophageal reflux disease: clinical and pathophysiological features (part I)] 189
Pancreatic involvement in systemic sarcoidosis. A case report. 188
Paraneoplastic Syndrome 187
Gut microbiota and related diseases: clinical features. 187
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly. 187
Evidence of RET/GDNF-related apolipoprotein B (APOB) activation and altered expression in patients with chronic intestinal pseudo-obstruction (CIPO) 186
Caratterizzazione genetico-molecolare e morfologica di un modello sperimentale di megacolon congenito non agangliare. 185
Advances in our understanding of the pathology of chronic intestinal pseudo-obstruction. 185
Aspetti clinici ed anticorpi anti-neurone nella malattia celiaca con disordini neurologici 184
Almost all irritable bowel syndromes are post-infectious and respond to probiotics: controversial issues. 184
Enteroendocrine profile of α-transducin immunoreactive cells in the gastrointestinal tract of the European sea bass (Dicentrarchus labrax) 183
Post-infectious Irritable Bowel Syndrome. 181
Zollinger-Ellison syndrome. Diagnosis and therapy. 180
Gastroesophageal reflux disease: therapeutic features (Part II)] 180
Gastro-oesophageal reflux and interstitial lung disease. 179
Neuroplasticità gastroenterica: dai geni all’infiammazione. 178
Chronic intestinal pseudo-obstruction: clinical features, diagnosis, and therapy. 178
Medical treatment of endocrine gastroenteropancreatic tumors. 177
Water-related techniques in colonoscopy: the end justifies the means! 175
Interactions between commensal bacteria and gut sensorimotor function in health and disease. 174
Clinical approach to diarrhea 174
Enteric neuroplasticity evoked by inflammation 174
Enteric neuropathy evoked by repeated cisplatin in the rat. 172
Plasma acylated ghrelin levels are higher in patients with chronic atrophic gastritis. 172
Enteric neuron involvement in dysmotilities and responses to inflammation. 171
A case of paraneoplastic inflammatory neuropathy of the gastrointestinal tract related to an underlying neuroblastoma: successful management with immunosuppressive therapy. 171
Unsolved problems in the management of patients with gastro-oesophageal reflux disease 170
Antiflagellin antibodies suggest infective participation in irritable bowel syndrome pathogenesis. 170
Mast cell neuromuscolar involvement in patients with severe gastrointestinal dysmotility (SGID). 169
Actual therapy of gastroesophageal reflux disease 168
Sympathetic hyperactivity in patients with ulcerative colitis. 168
Quality of life in patients with chronic pancreatitis 167
Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study. 167
Chronic intestinal pseudo-obstruction. 166
Malattia da reflusso gastroesofageo. 166
Delayed gastric emptying in functional dyspepsia 165
La malattia da reflusso gastroesofageo. 165
Sedation during colonoscopy and the benefits of lubrication 165
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 165
How to proceed in H pylori-positive chronic gastritis refractory to first and second line eradication therapy. 164
Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use. 163
Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome. 162
Molecular genetics of human enteric neuropathies. 160
Inflammatory neuropathies of the enteric nervous system 159
Lubrication during colonoscopy: a forgotten factor. 159
Routine duodenal biopsies: is it time to change our minds? 157
Quality of life and clinical indicators for chronic pancreatitis patients in a 2-year follow-up study. 157
Patient-reported outcomes and gut dysmotility in functional gastrointestinal disorders. 157
Review article: molecular, pathological and therapeutic features of human enteric neuropathies 156
Does colorectal endometriosis alter intestinal functions? A prospective manometric and questionnaire-based study. 156
A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation (IBS-C). 155
Assessment of the quality of life in chronic pancreatitis using Sf-12 and EORTC Qlq-C30 questionnaires. 153
Gastric endocrine tumors type I: treatment with long-acting somatostatin analogs 153
Totale 22.658
Categoria #
all - tutte 95.224
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.224


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.479 0 115 237 212 274 177 78 210 110 200 1.298 568
2022/20233.852 367 535 229 483 265 254 94 244 640 124 280 337
2023/20241.338 106 190 130 121 143 351 65 54 20 44 59 55
2024/20254.541 179 591 461 254 861 323 454 260 149 201 105 703
2025/20269.930 730 945 892 620 1.163 561 1.017 312 2.054 712 495 429
2026/2027702 303 399 0 0 0 0 0 0 0 0 0 0
Totale 35.604